产品名称
MISSION® esiRNA, targeting human CNKSR3
description
Powered by Eupheria Biotech
product line
MISSION®
form
lyophilized powder
esiRNA cDNA target sequence
GCTTTGTAGCGGAAATGGAGGATAAAGTTTTAACTGTGGTCAAGGTTTTAAATGGCATCTGTGACAAAACAATCCGATCTACCACAGATCCTGTGATGAGCCAGTGTGCATGTCTGGAGGAAGTTCACTTACCAAACATTAAACCTGGGGAAGGCCTGGGCATGTACATCAAATCAACCTATGATGGGTTACACGTGATTACTGGAACCACAGAAAATTCTCCTGCAGACAGATCTCAGAAGATTCATGCTGGTGACGAAGTCATTCAAGTTAATCAGCAAACTGTGGTGGGATGGCAGCTGAAAAATCTGGTGAAGAAATTGAGAGAGAATCCCACCGGAGTTGTGTTACTGCTTAAGAAGCGCCCCACCGGGTCTTTCAACTTTACTCCTGCTCCCCTGAAAAACCTACGGTGGA
Ensembl | human accession no.
NCBI accession no.
shipped in
ambient
storage temp.
−20°C
Quality Level
Gene Information
human ... CNKSR3(154043), MAGI1(154043)
General description
MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
Legal Information
MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany
存储类别
10 - Combustible liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
BAP1 immunohistochemistry and p16 FISH to separate benign from malignant mesothelial proliferations.
Brandon S Sheffield et al.
The American journal of surgical pathology, 39(7), 977-982 (2015-01-31)
A variety of immunohistochemical (IHC) stains have been proposed to mark either benign or malignant mesothelial proliferations. Loss of the p16 tumor suppressor (CDKN2A), through homozygous deletions of 9p21, is a good marker of mesotheliomas but lacks sensitivity. Recent reports
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持